Abstract
Individuals homozygous for haplotypes -2578-A/-1154-A/-634-G or -2578-A/-1154-G/-634-G in the promoter/5'UTR of the VEGF gene have a 1.8-fold increased risk of ALS in several European populations. We did not observe any significant association with single markers, or haplotype pairs, in a German sample of 580 sporadic ALS patients and 628 controls. However, the promoter SNP-1154 (rs1570360) was associated with affection status in women (p = 0.036), suggesting that the VEGF effect may be dependent on the sex ratio of the sample.
Publication types
-
Controlled Clinical Trial
MeSH terms
-
Amyotrophic Lateral Sclerosis / epidemiology*
-
Amyotrophic Lateral Sclerosis / genetics*
-
Cohort Studies
-
DNA Mutational Analysis
-
Female
-
Genetic Predisposition to Disease / epidemiology
-
Genetic Predisposition to Disease / genetics
-
Genetic Testing / methods*
-
Germany / epidemiology
-
Heterozygote
-
Humans
-
Male
-
Polymorphism, Genetic
-
Polymorphism, Single Nucleotide / genetics
-
Prevalence
-
Risk Assessment / methods*
-
Risk Factors
-
Sex Distribution
-
Sex Factors
-
Statistics as Topic
-
Vascular Endothelial Growth Factor A / genetics*
Substances
-
Vascular Endothelial Growth Factor A